Of those with known PD-L1 status, 152 (52.2%) patients had a Tumor Proportion Score (TPS) of 50% or higher, 93 (31.9%) exhibited a TPS of 1–49%, and 46 (15.9%) had a TPS of less than 1%. This evidence concerns the gene CD274 and neoplasm.